Because olorofim works against azole resistant infections, it could save many lives of affected patients. However, ipflufenoquin, could severely impact the new drug because it has the same ...

The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in ...

Since mid-2002, two new antifungal drugs — voriconazole, a third-generation azole, and caspofungin, a member of a new class of drugs called echinocandins — have been marketed in Spain.

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

It is active against Azole- and amphotericin B-resistant Aspergillus species and has a low propensity for drug-drug interactions. We are currently conducting preclinical profiling studies to ...

The efficacy and safety of a combination therapy including caspofungin and another antifungal (either AMB or an azole) in a small ... without a major concern about drug-related side effects.

JERSEY CITY, N.J., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug ...

Taking expired medications may not seem like a big deal, but Dr. Jamie Winn, a pharmacist and medical director at Universal Drugstore, tells The Post that some of them can do serious damage to ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...